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Charcot-Marie-Tooth hereditary motor and sensory neuropathy (CMT) is primarily an autosomal dominant disease most often caused by a duplication in the peripheral myelin protein-22 gene. 1 Shortly after the first descriptions of CMT, Harringham, in England, reported an affected family having X-linked inheritance.
2 This X-linked pattern, the second most common type of CMT, is usually caused by mutations in the GJB1 gene encoding a gap junction protein (connexin-32).
3
More than 400 mutations in GJB1 have been reported, the overwhelming majority of which are missense mutations. [4] [5] [6] Recently, Tomaselli et al. reported a variant (c.*15C>T) in the 3 0 untranslated region mutation (UTR) of GJB1 in 2 small nuclear families. 7 We evaluated a large family with this 3 0 UTR mutation in which we confirmed its pathogenicity and for which we provide details of clinical manifestations.
METHODS
This 8-generation family ( Fig. 1 ) has been followed for more than 40 years by 1 author (T.D.B.). With informed consent, under protocols approved by the University of Washington (UW) institutional review board, medical records were reviewed and blood or saliva samples collected from 5 and 11 family members, respectively.
Motor nerve conduction studies (MNCS) were performed on the upper limbs with surface electrodes, recording median and ulnar compound muscle action potentials (CMAPs) from the abductor pollicis brevis and abductor digiti minimi muscles, respectively. Some patients also underwent MNCS of the lower limbs, where fibular and tibial CMAPs were recorded from the extensor digitorum brevis and abductor hallucis muscles, respectively. We did not have consistent records for sensory nerve conduction or needle electromyography data.
DNA was extracted from buffy coat fractionated from blood. DNA from saliva samples collected using the Orange Discover ORG-500 kit (DNAGenotek, Ottawa, Ontario, Canada) was extracted using prep IT L2P reagent (DNAGenotek). Exome sequencing was obtained from the UW Center for Precision Diagnostics on 1 subject. Molecular and parametric linkage analyses methods are provided in the Supplementary Material (available online).
RESULTS
Family and Clinical Findings. Descendants of the original couple in this family emigrated from Scotland to the United States in the 19th century. By pedigree analysis individual I-2 was a likely mutation carrier. There are 22 affected males, at least 20 obligate carrier females and no male-to-male transmission of the disorder, highlighted by individuals III-4, III-5, and III-8. The subtle onset, slow progression, and disease manifestations are typical of CMT. The most common findings are pes cavus, bilateral mild to moderate foot drop, hypoactive or absent tendon reflexes, and decreased vibratory sensation in the feet. Weakness and atrophy of hand muscles often develops. Several persons require ankle-foot orthoses (AFOs) but no use of a wheelchair. Two individuals have had surgical correction of pes cavus.
Manifestations in carrier females varied greatly. The index subject (V-10) was one of the more severely affected persons. At 20 years of age she noted "dragging" of her feet. By age 28 she had bilateral foot drop, bilateral hand atrophy, mild pes cavus, and marked loss of vibatory sensation in the feet and hands. She required AFOs by age 30.
At age 39, electrodiagnostic (EDx) studies showed a demyelinating neuropathy ( Table 1 ). The youngest examined female carrier (VIII-2) was 10 years old and asymptomatic, but showed mild distal muscle weakness of hands and feet and slight difficulty with heel walking. The oldest examined female carrier (IV-12) was 83 years of age. At age 8 she had high arches, difficulty running, and frequent ankle sprains. At age 43, she showed depressed tendon reflexes, pes cavus, mild atrophy of hand muscles, and decreased vibratory sensation in her feet. EDx studies showed an axonal neuropathy. At age 83, she remained ambulatory with a walker, and had mild bilateral footdrop. Hand atrophy was more pronounced and vibration sensation was absent to the knees. Five women (IV-2, V-11, V-12, V-21, VI-5) in their 40s and 50s have had mildly unsteady gait with weakness of ankle dorsiflexion, high-arched feet, and atrophy of hand muscles. Two women (V-10, VI-5) have used AFOs. One has had carpal tunnel surgery. Two women (V-12, VI-10) have had symptoms of neuropathic pain in the hands and/or feet. Several females have been asymptomatic, but, on examination, showed depressed tendon reflexes and mild loss of vibratory sensation. If mild findings on examination are included, the disease is fully penetrant in males and females.
EDx studies were available for 15 persons and showed no consistent difference between males and females (Table 1) . MNCS varied from normal, to mildly slow, to occasionally within the "demyelinating" range. CMAPs were often normal but sometimes reduced. Three females had repeat studies over 4-24 years with relatively little change.
Genetic Analysis. Given the X-linked inheritance pattern in the pedigree, GJB1 was analyzed by commercial laboratories on 2 separate occasions but no mutation was identified. With the report of GJB1 *15C>T, we reevaluated the available exome sequence of affected subject VII-8 and found this variant. 7 Sanger sequencing confirmed the variant and identified it in 4 other affected relatives. The mutation creates a BstE II restriction enzyme recognition site making genetic screening for this mutation relatively simple (Fig. 2) . Using genotypes from 18 family members (Fig. 1) , 2-point parametric linkage analysis under an X-linked dominant model provided strong evidence of linkage between the GJB1 c.*15C>T allele and CMTX, with a LOD 5 4.91.
We hypothesized the mutation would lead to RNA instability or affect transcript decay rate. Other than fresh blood, no tissues were available from patients. The expression databases lack consensus regarding GJB1 expression in blood; some show very low expression by RNAseq or RNA microarray (BioGPS, GTEx). Given the high sensitivity of polymerase chain reaction to detect RNAs present in very low copynumber, we tried to amplify the GJB1 cDNA fragment from isolated blood RNA from a patient and normal controls. Despite using multiple primer sets in different regions of GJB1, we were unable to obtain a reverse transcript-polymerase chain reaction product. Normal values listed in parentheses. Abnormal values in italics. M, male; F, female; DML, distal motor latency; Amp, amplitude; CV, conduction velocity.
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DISCUSSION
The majority of mutations in GJB1 are missense but rare ones have been described in the 5 0 UTR. 8 Recently, a GJB1 mutation (c.*15C>T) in the 3 0 UTR was reported in 2 nuclear families each with only a single affected male, precluding proof of cosegregation with disease. 7 The present study has documented cosegregation of the c.*15C>T GJB1 mutation in 4 branches of a large family, with confirmation by linkage analysis. Affected males have a typical CMT syndrome and female carriers show mild manifestations of the disease with great variability.
Results of EDx studies are also variable, typically showing normal or mildly slow motor nerve conduction velocity and sometimes low CMAP. These characteristics are similar to the CMT syndrome associated with other mutations in GJB1. [4] [5] [6] Variability of manifestations in carrier females is presumably the result of random X inactivation, although Siskind et al. were not able to document this phenomenon. 9 Previous EDx studies in CMTX have demonstrated motor conduction slowing in the intermediate range (30-40 m/s in the upper limb), which we observed in 2 males and 1 female. 10 Pathological studies have shown both demyelination and axon loss in CMTX. In the present family, we observed a correlation between conduction slowing and CMAP amplitude reduction, and in subsequent studies we observed axon loss over time.
Without special attention to the 3 0 UTR of GJB1, this mutation would be missed by many commercial genetic tests because it lies outside the normal coding region of the gene. Thus, the frequency of this particular mutation remains unknown. We have shown that the mutation creates a new DNA restriction digest site providing a simple way to screen for the mutation.
GJB1 codes for the gap junction protein connexin-32 (Cx32). How mutations in GJB1 produce peripheral neuropathy in CMTX1 is not entirely clear. [11] [12] [13] Transgenic mouse models indicate that altered synthesis or trafficking and loss of gap junction function is likely most important. Also, impaired cytoskeletal organization and axonal transport defects appear to precede demyelination, suggesting the early occurrence of an axonopathy. 14 The biological consequences of this UTR mutation remain unknown. The 3 0 UTR of other genes plays an important role in gene expression by effects on polyadenylation, translation efficiency, localization, transport, and stability of mRNA. 15 Tomeselli et al. speculated that this variant may create a 5 0 donor splice site leading to aberrant splicing within the 3 0 UTR. 7 This could affect mRNA stability leading to decreased GJB1 protein Cx32. Patients with UTR mutations (including reported mutations in the 5 0 UTR) present typical phenotypes of CMTX1, as seen in cases with missense mutations in GJB1. In-vitro and in-vivo models of the disease indicate that most GJB1 missense mutations likely cause loss of function of Cx32. 14, 16 If the effect of the UTR mutations is mediated through RNA instability, this would be equivalent to a loss of function. Because we were unable to identify GJB1 RNA in peripheral white blood cells in either normal individuals or mutation carriers, further investigation of this question will require additional techniques and other tissues.
